Development of an AAV-CRISPR-Cas9-based treatment for dominant cone-rod dystrophy 6 is a research paper published in Molecular Therapy — Methods & Clinical Development (2023). On theSindex it has a DataRank of 0.401. It has been cited 8 times, with 8 citing works in its 1-hop citation network.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.330
From this paper's citation signal
Citation Network Contribution
0.0717
From 6 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 8 citers.
NEI NIH HHS
Grant: R01 EY024280
NEI NIH HHS
Grant: R01 EY028968
NEI NIH HHS
Grant: T32 EY007132
NIH HHS
Grant: S10 OD028476
National Institutes of Health
Grant: 1R01EY028968-01A1
DEVELOPMENT OF AAV-CRISPR/CAS9-BASED THERAPIES FOR CONE ROD DYSTROPHY
FWCI
0.73
Citation Percentile
0.7%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals